Intrexon Corp (XON)

21.89
0.22 0.99
NYSE : Health Care
Prev Close 22.11
Open 22.00
Day Low/High 21.80 / 23.02
52 Wk Low/High 18.41 / 32.90
Volume 811.15K
Avg Volume 1.19M
Exchange NYSE
Shares Outstanding 119.61M
Market Cap 2.64B
EPS -1.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Back to Earnings Next Week: Cramer's 'Mad Money' Recap (Friday 5/5/17)

Back to Earnings Next Week: Cramer's 'Mad Money' Recap (Friday 5/5/17)

With the Fed and the healthcare vote out of the way, markets will focus on earnings in the week ahead.

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Good, the Bad and the Ugly; What Troubles Me: Doug Kass' Views

Doug Kass shares his thoughts on Facebook, Allergan and Eli Lilly.

Synthetic Biologics Reports Preclinical Data Demonstrating SYN-005 Provides Protection From Pertussis In Neonatal Animal Study

-- Study Results Further Support Advancement of SYN-005 into Clinical Trials for Treatment and Prevention of Pertussis --

Takeaways and Observations; The Good, the Bad and the Ugly: Doug Kass' Views

Takeaways and Observations; The Good, the Bad and the Ugly: Doug Kass' Views

Doug Kass shares his thoughts on Apple, Allergan and Western Digital.

Pfizer, Intrexon, Raytheon: 'Mad Money' Lightning Round

Pfizer, Intrexon, Raytheon: 'Mad Money' Lightning Round

Jim Cramer says Pfizer needs to do a deal and buy someone; and he thinks Raytheon is a terrific stock.

Twitter, Netflix, MetLife: Doug Kass' Views

Twitter, Netflix, MetLife: Doug Kass' Views

Doug Kass shares his thoughts on Twitter and talks about Sears.

Intrexon Creates Precigen, Inc. And Accelerates Strategic Review Of Structural Options Related To Health Assets

Geno Germano to Step Down as President; Randal Kirk to Remain CEO

Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco

Shell Deal Hands Biggest U.S. Oil Refinery to Saudi Aramco

Saudi Aramco will assume control of the biggest oil refinery in the U.S. after a $2.2 billion deal with Shell that exits a joint venture in Port Arthur, Texas.

XON: Insiders vs. Shorts

The most recent short interest data was recently released for the 01/31/2017 settlement date, and Intrexon Corp is one of the most shorted stocks of the Russell 3000, based on 11.99 "days to cover" versus the median component at 5.13. There are a number of ways to look at short data, but one metric that we find particularly useful is the "days to cover" because it considers both the total shares short and the average daily volume of shares typically traded.

Noteworthy Thursday Option Activity: XON, PBYI, KPTI

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Intrexon Corp , where a total of 12,560 contracts have traded so far, representing approximately 1.3 million underlying shares. That amounts to about 99.4% of XON's average daily trading volume over the past month of 1.3 million shares.

5 Stocks Setting Up for Big Breakouts

5 Stocks Setting Up for Big Breakouts

Here's how to rake in the gains off some potential big breakouts.

Intrexon To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform

Intrexon To Acquire GenVec To Expand Industry-Leading Gene Delivery Platform

GenVec's AdenoVerse™ to be Integrated into Intrexon's Proprietary Synthetic Biology Platform

Allergan, Apple, Facebook: Doug Kass' Views

Allergan, Apple, Facebook: Doug Kass' Views

Doug Kass shares his thoughts on buying retail, and discusses why he's favoring the short side in a big way.

Oragenics Shareholder Update

Oragenics Shareholder Update

Oragenics, Inc. (NYSE MKT:OGEN.